Poor
Needs Revision
Patient Risk:
Low
Summary
Most claims concern pricing, discounts, generic availability, or market availability, none of which are addressed by the supplied label. The label supports availability of 10 mg Valium tablets but does not support the claimed liquid formulation.
Category Scores
Accurate Statements
Diazepam 10 mg is available in tablet form.
The DESCRIPTION section states that Valium is available for oral administration as 10 mg tablets.
Unsupported Statements
Cash prices for diazepam 10 mg vary depending on the pharmacy, location, formulation, and quantity.
The supplied label contains no information about cash prices or pricing factors.
Diazepam 10 mg is available in liquid formulations.
The label describes 10 mg tablets but does not describe or establish availability of a liquid formulation.
Diazepam is generally available as a generic in many markets.
The label does not address generic availability or market distribution.
Generic diazepam is usually cheaper than brand-name diazepam.
The label contains no information about generic or brand-name pricing.
Discount cards or coupons can lower the cash price of diazepam without insurance.
The label does not discuss discount cards, coupons, insurance, or cash prices.
Discounted diazepam prices can be substantially lower than the standard cash register price, depending on the pharmacy.
The label contains no pharmacy-specific pricing or discount information.
Contradictions
Important Omissions
The response should distinguish the label-supported availability of 10 mg tablets from unsupported claims about liquid formulations.
Importance:
Moderate
The response should state that the supplied prescribing information cannot verify pricing, generic availability, discount programs, or pharmacy-specific savings.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The claims do not address dosing, treatment, contraindications, warnings, or interactions. The unsupported formulation and pricing claims are not directly safety-related in the supplied label context, although formulation availability is not established.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Needs Revision
Primary Issue
Five claims are outside the scope of the supplied label, and the liquid formulation claim is not supported by it.
Suggested Improvement
Limit label-based conclusions to the documented availability of oral 10 mg tablets and explicitly identify pricing, generic availability, discount programs, and liquid formulations as not addressed by the supplied prescribing information.